14 Matching Annotations
  1. Feb 2022
  2. Jan 2022
  3. Dec 2021
    1. Munro, A. P. S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Gokani, K., Goodman, A. L., Green, C. A., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A. A., Kwok, J., … Appleby, K. (2021). Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial. The Lancet, S0140673621027173. https://doi.org/10.1016/S0140-6736(21)02717-3 s

  4. Nov 2021
  5. Oct 2021
  6. Aug 2021
  7. Jul 2021
    1. CitiNewsroom. (2021, July 15). The AstraZeneca Africa Director, Barbara Nel, has disclosed that a total of 1.6 billion fully funded COVID-19 vaccines would be made available for COVAX dependent countries later this year through to 2022. | Watch the full interview with @benkoku here: Https://t.co/kw3BKzMclU https://t.co/6gQ1DZMnB6 [Tweet]. @Citi973. https://twitter.com/Citi973/status/1415697599236018181

  8. Apr 2021
  9. Mar 2021
  10. Oct 2020